ACQUISITION (Details) (USD $)	12 Months Ended					0 Months Ended		12 Months Ended					0 Months Ended				12 Months Ended									12 Months Ended		0 Months Ended		12 Months Ended
	Dec. 31, 2012	Dec. 31, 2011	Dec. 31, 2010	Feb. 07, 2012	Dec. 29, 2010 Series A Preferred Stock	Dec. 29, 2010 Preferred Stock Series A Preferred Stock	Dec. 31, 2012 Third Security Convertible Promissory Notes Convertible Debt	Dec. 31, 2012 PGxHealth Note Payable (the First Note) Notes Payable, Other Payables	Dec. 31, 2012 PGxHealth Note Payable (the Second Note) Notes Payable, Other Payables	Dec. 31, 2012 Customer relationships	Dec. 31, 2012 Assay royalties	Dec. 31, 2012 Tradenames and trademarks	Sep. 21, 2012 ScoliScore Assay	Sep. 21, 2012 ScoliScore Assay Axial	Sep. 21, 2012 ScoliScore Assay Axial Accrued expenses	Sep. 21, 2012 ScoliScore Assay Certain Of Axial's Creditors	Dec. 31, 2012 ScoliScore Assay Acquired technology	Dec. 31, 2012 ScoliScore Assay Customer relationships	Dec. 31, 2012 ScoliScore Assay Assay royalties	Dec. 31, 2012 ScoliScore Assay Tradenames and trademarks	Dec. 31, 2011 Familion	Dec. 31, 2010 Familion	Dec. 29, 2010 Familion notes_payable	Dec. 29, 2010 Familion Series A Preferred Stock	Dec. 29, 2010 Familion Warrant	Dec. 31, 2010 Familion Selling, general and administrative expenses	Dec. 31, 2010 Familion Selling, general and administrative expenses Series A Preferred Stock	Dec. 29, 2010 Familion Preferred Stock Series A Preferred Stock	Dec. 31, 2010 Familion Third Security Convertible Promissory Notes Convertible Debt	Dec. 31, 2012 Familion PGxHealth Note Payable (the First Note) Notes Payable, Other Payables	Dec. 31, 2012 Familion PGxHealth Note Payable (the Second Note) Notes Payable, Other Payables
Business Acquisition [Line Items]
Acquisitions of intangibles			$ 0										$ 3,400,000	$ 200,000
Future payments to acquire intangible assets															800,000
Future payments to acquire intangible assets, amount held In escrow for one year																100,000
Finite-lived intangible asset, useful life										15 years	7 years	7 years					7 years	15 years	7 years	7 years
Finite-lived intangible assets acquired													3,900,000
Goodwill, acquired during period													500,000
Debt instrument, face amount																													6,000,000	8,600,000	1,000,000
Private Placement, net, shares						2,586,205																						2,586,205
Convertible notes, common stock callable				3,000,000	1,293,102																			1,293,102
Common stock warrant, exercise price					2.32	2.32																		2.32	0.58
Preferred stock, common shares callable																								15,517,228
Proceeds upon conversion of preferred stock																								3,000,000
Issuance of preferred stock and related warrants, net	0	0	5,791,000																			6,000,000
Number of notes payable																							2
Debt instrument, term								3 years	1 year																					3 years	1 year
Debt instrument, interest rate, stated percentage							16.00%	10.00%	6.50%																					10.00%	6.50%
Business Combination, Consideration Transferred [Abstract]
Cash																						6,000,000
Notes payable																						9,628,000
Assumed liabilities																						452,000
Contingent liabilities																						2,736,000
Fair value of consideration transferred																4,400,000						18,816,000
Business Combination, Acquisition Related Costs																										800,000	200,000
Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Net [Abstract]
Working capital, net																						3,222,000
Property and Equipment																						639,000
Identifiable intangible assets																						8,680,000
Total identifiable net assets																						12,541,000
Goodwill	6,918,000	6,440,000	6,275,000																			6,275,000
Total purchase price																						18,816,000
Fair value accounts recievable, net																						3,100,000
Fair value accounts recievable, gross																						7,000,000
Uncollectible accounts recievable																						3,900,000
Goodwill purchase price adjustment	0	165,000	0																		200,000
Business Combination, Pro Forma Information [Abstract]
Revenue—Supplemental pro-forma results																						33,733,000
Net loss—Supplemental pro-forma results																						$ (7,716,000)